Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled by iron: Preparation, properties and drug release ability by Суходуб, Людмила Борисівна et al.
Accepted Manuscript
Composite material based on hydroxyapatite and multi-walled
carbon nanotubes filled by iron: Preparation, properties and drug
release ability
L.B. Sukhodub, L.F. Sukhodub, Yu.I. Prylutskyy, N.Yu.
Strutynska, L.L. Vovchenko, V.M. Soroca, N.S. Slobodyanik,
N.G. Tsierkezos, U. Ritter
PII: S0928-4931(18)30270-4
DOI: doi:10.1016/j.msec.2018.08.019
Reference: MSC 8813
To appear in: Materials Science & Engineering C
Received date: 26 January 2018
Revised date: 12 July 2018
Accepted date: 6 August 2018
Please cite this article as: L.B. Sukhodub, L.F. Sukhodub, Yu.I. Prylutskyy, N.Yu.
Strutynska, L.L. Vovchenko, V.M. Soroca, N.S. Slobodyanik, N.G. Tsierkezos, U. Ritter
, Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled
by iron: Preparation, properties and drug release ability. Msc (2018), doi:10.1016/
j.msec.2018.08.019
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled by 
iron: preparation, properties and drug release ability 
 
L.B. Sukhodub
1
, L.F. Sukhodub
1
, Yu.I. Prylutskyy
2
, N.Yu. Strutynska
2
, L.L. Vovchenko
2
, V.M. 
Soroca
2
, N.S. Slobodyanik
2
, N.G. Tsierkezos
3
, U. Ritter
3*
 
 
1
Sumy State University, Sumy 40007, Ukraine
 
2
Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine 
3
Technical University of Ilmenau, Ilmenau 98693, Germany 
 
*Corresponding author: Uwe Ritter (E-mail: uwe.ritter@tu-ilmenau.de) 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Abstract 
The novel bioactive composite material based on hydroxyapatite and multi-walled carbon 
nanotubes filled by iron was synthesized by the "wet chemistry" method and characterized in 
detail by various experimental techniques including the X-ray diffraction, Fourier transform 
infrared and energy-dispersive X-ray fluorescence spectroscopy, thermogravimetric and 
differential thermal analysis. The swelling behaviour was quantified by measuring the changes in 
sample weight as a function of sample immersion time in a phosphate buffered saline (PBS). 
Bioactivity test was carried out by soaking the samples in PBS. The material composition 
influence on the model drug release was studied using the high-performance liquid 
chromatography method. Finally, the mechanical properties (maximal relative deformation, 
strength and Young's modulus) of the samples under loading were investigated too. The findings 
clear demonstrate the possibility of application of the created composite material in 
bioengineering of bone tissue to fill bone defects of various geometries with the function of 
prolonged release of the drug. It is assumed that this composite material can be used in 3D 
modeling of areas of bone tissue that have to bear a mechanical load. 
 
Key words: hydroxyapatite, multi-walled carbon nanotubes filled by iron, drug release kinetics, 
bioactivity test, strength properties 
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1. Introduction 
Nanocrystaline hydroxyapatite (HA) is widely used as an excellent material for the bone tissue 
engineering, in drug delivery systems, as biosensor and for many other applications due to 
chemical and biological similarity to the mineral part of bone [1,2]. HA is the most 
biocompatible orthophosphate among of all inorganic Ca/P materials. But it has many 
disadvantages namely negligible resorption rate, low mechanical strength and toughness, high 
shrinkage and deformation during sintering and, finally, unregulated biological properties. For 
these reasons in many cases HA is used in combination only with a biopolymer as a composite 
material.  
Alginates are linear unbranched polysaccharides containing varying proportions of beta-
D-mannuronate (M) and alpha-L-guluronate (G) residues. Sodium alginate (Alg) is very often 
used because of the low cost, biocompatibility, non-toxicity, chelating ability and of its potential 
use for the drug delivery systems [3-5]. Alg biopolymer carrying carboxylic group is able to 
form complexes with metal ions and is effective for the removal of heavy toxic metal cations [6]. 
Alg is a typical polyelectrolyte, it can be useful for sensing and modulating external chemical 
signals in the aqueous media [7]. The cross linking of Alg molecules with metal ions 
significantly reduced the Alg-based hydrogel swelling, and thus delayed the release of the 
entrapped drugs. As a result, Algs are being exploited in the controlled drug release systems [8-
10].  
Chlorhexidine (CH) is very common in medicine as an antibacterial agent against gram-
positive and gram-negative bacteria and fungi [11]. The typical synthetic HA-based 
biocomposites include such biopolymers as collagen, chitosan, polylactide, cellulose, and many 
others bioactive substances [12], including the multi-walled carbon nanotubes (MWCNTs), as a 
promising candidate to prevent erosion of teeth [13]. The stimulus for the use in material science 
of CNTs, discovered in 1991 [14], is a set of their properties: remarkable mechanical and unique 
electrical properties, high thermal and chemical stability [15]. The excellent HA bioavailability 
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can be supplemented by the mechanical properties of CNTs in composite material. The 
formation of HA-based composites with CNTs content may logically lead to an expansion of the 
spectrum of properties without affecting biological activity, which is key to biomedical 
applications. The promise of CNT-Alg scaffolds in tissue engineering has been demonstrated in 
one of the first investigations of such composites [16], which has been confirmed in many 
further works [17,18]. CNTs have small dimensions, high strength and stiffness, high ratio of the 
length to diameter, that give them the excellent potential to use. MWCNTs consist of many 
graphene sheets, arranged concentrically. They have a diameter of 2 to 100 nm and a length from 
several micrometers to several millimeters. The chemistry of their surface allows them to be 
functionalized for specific applications [19]. MWCNTs are used in biosensors for determination 
of drugs and metal ions [20-35]. Since HA, as a chemical compound, is useful in the separation 
of proteins or nucleic acid by adsorption chromatography, the HA-based hybrid composites also 
can potentially be used in the field of sensory systems. Now MWCNTs are regarded as the most 
attractive functional excipients for nanomedicine [36,37], since they are capable to penetrate 
through a cellular plasma membrane [38], interact with DNA [39] can be tumor-targeted and 
have a central hollow core that can be loaded with a therapeutic drug [40]. The ability of 
MWCNTs to induce temperature increases compatible with thermal ablation and short near IR 
light exposure time suggests that these nanostructures may be useful as photothermal mediators 
[41]. At the same time, it should be noted, that CNTs can exhibit certain toxicity due to metallic 
impurities of catalytic action (iron, cobalt, nickel) [19], therefore it is necessary to pay attention 
to the biomaterials synthesis. On the other hand, the presence of CNTs in the biocomposite has 
no harmful side effects and could even enhance its bioactivity [42]. Finally, the modification of 
MWCNTs (intercalation and filling the internal cavities with different chemical elements) is a 
key tool to modulate their biodistribution and toxicity [43-45].  
Hence, the aim of this research was to study the influence of MWCNTs filled by iron on 
the ability to adsorb and prolonged release of the drug and on the mechanical properties of the 
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formed composite biomaterial on the basis of HA, in order to use the material to create bone 
tissue model areas that are capable of bearing a mechanical load.  
 
2. Materials and methods 
2.1. Materials 
The following materials and chemicals were used: MWCNTs filled by iron (MWCNT+Fe 
nanoparticles with a diameter 20-80 nm and a length up to 100 μm), prepared in accordance with 
[44, 46]. All structural parameters (SEM, TEM) together TG and XRD analysis of the used MWCNT are 
given previous and reported in [46]. The samples contain between 5 and 7 m% of iron. The main species 
are α-Fe together with small amounts of FeC and iron oxides. The clusters of iron or its compounds 
have an with average diameter of 10–15 nm and lengths of 120–140 nm.  
Calcium nitrate tetrahydrate Ca(NO3)2∙4H2O, diammonium dihydrophosphate ((NH4)2HPO4), 
ammonium hydroxide NH4OH, calcium chloride CaCl2 (Sinopharm Chemical Reagent Co., Ltd), 
Alg ((low viscosity, E407, China), commercially available pharmaceutical CH (0.05%). All 
reagents were analytically grade and used as received. 
 
 
2.2. Сomposite material obtaining 
2.2.1. HA suspensions 
At the first stage, HA suspension was obtained according to the “wet chemistry” method [47]. 
Briefly, for HA synthesis 50 ml of Ca(NO3)2·4H2O (0.167 M) and 50 ml of (NH4)2HPO4 (0.1 M) 
were used. Ammonium hydrophosphate was added dropwise to the calcium nitrate tetrahydrate. 
The pH of about 11 was obtained by the addition of ammonia solution. The reaction was carried 
out by heating of the reactive mixture at 80 
оС for 10 min. The product was aged for 24 h in the 
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closed, but not sealed volume, than washed by distilled water until the washing solution was 
neutral. The solid fraction was separated by centrifugation. The moisture of the final НА 
suspension was about 90%. 
2.2.2. Alg/MWCNT+Fe suspension 
0.75 g of Alg was dissolved in 50 ml of deionized water at 37 °C for 5 h and 1.5% by weight Alg 
suspension was formed. 0.0025 g of MWCNT+Fe in the form of a fine powder was added to the 
Alg suspension, while the concentration of MWCNT+Fe in Alg solution was 0.05 mg/ml. The 
mixture was treated with ultrasound of low power (to prevent heating) for 20 min. As a result, a 
homogeneous stable Alg/MWCNT+Fe suspension has been formed.  
 
2.2.3. HA-Alg and НА-Alg/MWCNT+Fe beads 
6.5 g of Alg/MWCNT+Fe suspension (p.2.2.2) was added to 8 g of HA suspension (p.2.2.1) and 
mixed with ultrasound for 10 min. Thus, in obtained mixture the final weight ratio of dry powder 
MWCNT+Fe for the dry powder of HA was 0.4 mg:1 g. The mixture was dripped into a solution 
of 0.25 M calcium chloride for 2 h, after which the beads formed were separated from the 
solution by filtration, thoroughly washed with deionized water and dried at room temperature. 
Subsequently, the samples were called as HA-Alg/MWCNT+Fe.  
For the comparison of physical and chemical properties, beads were obtained for the 
above technology, but without the content of MWCNT+Fe. Subsequently, these samples were 
called as HA-Alg (37). For further research, part of this sample was sintered at 700 °C for 1 h 
and the samples were called as HA-Alg (700). 
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2.3. Analytical Methods 
2.3.1. SEM analysis  
The surface morphology of the samples was examined using a scanning electron microscope 
(SEM, REMMA-102), produced by SELMI (Ukraine). Images were made in the secondary 
electron mode with an accelerating voltage 20 kV and a beam current of 1-10 A.  
 
2.3.2. XRD analysis 
The X-ray diffraction studies of the prepared samples were performed using the Shimadzu XRD-
6000 diffractometer with Cu-Kα radiation. The data were collected over the 2θ range 5.0–60.0° 
with step of 0.02 ° and counting time of 2 s. 
Identification of the crystal phases was performed using the JCPDS (Joint Committee on 
Powder Diffraction Standards) card catalog. More details in [48]. 
The average crystallite size (L; in nm) along [002] direction can be estimated from the 
corresponding peak broadening by the Scherrer equation 
L = kλ/βmcos θ, 
where k is the constant, dependent on the crystallite shape (k=1 is taken), λ (in nm) is the 
wavelength of X-ray radiation, βm is an integral width of (002) peak, in which physical 
broadening occurs only due to the small sizes of the CSR (coherent scattering region), θ is the 
diffraction angle. 
2.3.3. FTIR analysis 
Fourier transform infrared spectra (FTIR) were obtained using PerkinElmer Spectrum BX 
spectrometer in the range 400-4000 cm
-1
 (at 1 cm
-1 
resolution) for the samples pressed into the 
pellets of KBr. 
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2.3.4. Determination of Са/P molar ratio  
The Ca/P ratio was determined using the energy-dispersive X-ray fluorescence spectrometer 
ElvaX Light SDD. The spectrometer is designed for express qualitative and quantitative analysis 
of the composition of metal alloys, powders, liquids, deposits on the filter elements, biological 
samples, food products on the content of chemical elements from Na (atomic number Z=11) to U 
(Z=92) in a wide range of concentrations. The estimation accuracy of the mass fractions of 
metals in a light matrix is not worse than 1 ppm. The following parameters were used to estimate 
the Ca/P ratio. The voltage of the Rh anode X-ray tube was 12 kV. Calcium and phosphorous 
concentrations were estimated by the regression analysis method for HA samples only. 
2.3.5. ТGA/DТА analysis 
The weight loss and thermal behaviour of prepared samples were investigated using Shimadzu 
simultaneous TGA/DTA (thermogravimetric and differential thermal analysis) analyzer DTG-
60H. The samples were heated in a platinum crucible in air with the rate 10°С/min from the 
room temperature to 600 °С. α-Al2O3 was used as a standard sample.  
 
2.3.6. Swelling studies 
The swelling behaviour was quantified by measuring the changes in sample weight as a function 
of sample immersion time in phosphate buffered saline (PBS) [49] at pH=7.4. It is a water-based 
salt solution containing disodium hydrogen phosphate (10 mmol/l), sodium chloride (137 
mmol/l), potassium chloride (2.7 mmol/l) and potassium dihydrogen phosphate (1.8 mmol/l). 
The osmolarity and ion concentrations of the solutions match those of the human saline. The 
appropriate quantity of each component was dissolved in 1 liter of distilled water to obtain the 
specified concentration.  
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The samples were in beads form and each sample mass was 0.1 g. The swollen samples 
were weighed after blotting with a filter paper to remove the surface liquid. The swelling ratio 
(Sw) was calculated using the following equation [50] 
%100
)(



o
ot
w
W
WW
S , 
where W0 is the initial sample weight, and Wt is the final weight of the swollen sample.  
 
2.3.7. Determination of drug release kinetics 
The material composition influence on the drug release was investigated in this experiment. The 
pharmaceutical 0.05 mas.% CH solution was used as a model drug. The beads of НА-Alg (0.17 
g) and HA-Alg/MWCNT+Fe (0.17 g) were placed into 150 ml of PBS (pH=7,4) and incubated at 
37 °C with continues shaking 115 rpm. The rate of drug release from composites was determined 
by taking of 1500 μl aliquots of PBS from each experimental tube after 1, 2, 24, 48, 72 and 120 
h. An equal volume of the fresh medium then was added back to maintain a constant initial 
volume in the tubes. The drug release from experimental samples was studied using high-
performance liquid chromatography (HPLC, Angilent Technologies 1200, detector with UV-Vis 
Abs, detection at λ=280 nm, column C18 (Zorbax SB-C18 4.6×150 mm, 5 µm). The data 
acquisition and processing was made with software Empower 2. The next mobile phase was 
used: 68% of 0.05 M potassium hydrogen phosphate buffer with 0.2% triethylamine (рН=3.1 at 
21 
oС); 32% of acetonitrile. Isostatic treatment was applied at a rate of eluent elution 2 ml/min 
and temperature of analytical column 40 
o
C. The method of eluent components pre-mixing 
followed by 30 min sonication was applied to reduce errors in measuring of the substance with 
small component concentrations. 
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2.3.8. Bioactivity measurement 
Bioactivity test was carried out by soaking the samples in PBS. 0.2 mg of each sample was 
immersed into glass tube with 10 ml of PBS solution for 72 h. The samples were shaken at 60 
rpm at 37 
o
C. The pH values of the PBS solution with experimental samples were measured in 
pre-determined time intervals using a pH meter (pH 150 MI). The pH of pure PBS (without a test 
samples) was taken as a control.  
2.3.9. The measurements of compressive strength 
To measure the strength under the uniaxial compression, the specimens of HA-Alg and HA-
Alg/MWCNT+Fe were prepared in the form of tablets with diameter 5 mm and thickness 2 mm 
by cold pressing of granulated powder HA-Alg and HA-Alg/MWCNT+Fe in molds using the 
hydraulic press (at ~100 MPa). The mechanical properties of the specimens under loading were 
investigated using the original automated equipment [51]. 
 
3. Results and discussion 
3.1. SEM investigations  
Fig. 1 demonstrates the SEM images of the surface of HA-Alg/MWCNT+Fe and HA-Alg 
samples. The resulting images show a variety of surface structures. Thus, a more dense and 
homogeneous surface structure have HA-Alg/MWCNT + Fe samples compared to HA-Alg. 
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Fig. 1. SEM images: the bead surface of HA-Alg/MWCNT+Fe (a) and HA-Alg (b) samples; the 
cross-section of the bead of HA-Alg/MWCNT+Fe (c) and HA-Alg (d) samples; the cross section 
site of HA-Alg/MWCNT+Fe (e) and HA-Alg (f) samples. 
3.2. XRD investigations 
XRD investigations were carried out for the samples HA-Alg and HA-Alg/MWCNT+Fe. By the 
formation of the composite material, the suspension of Alg/MWCNT+Fe was added to the pre-
synthesized HA, which means that it did not affect the formation of crystallites and the structure 
of the HA. Therefore, XRD spectra for a sample of HA-Alg dried at the temperature of 37 
o
C, 
Fig. 2(1) and sintered at 700 °C, Fig. 2(2) are shown. According to XRD, the sample of HA-Alg 
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contains nanoscale particles, as evidenced by the extension of reflexes for this sample. After its 
sintering at 700 С, formation of monophase phosphate of apatite type and increase of its 
crystallinity degree was noted. Thus, the formation of the Calcium Deficiency Hydroxyapatite 
(PDF Number: 000-86-1201) was established.  
 
 
 
Fig. 2. Diffraction patterns from samples НА-Alg: dried at 37 oC (1) and sintered at 700 oC (2). 
 
Table 1. Crystal structure parameters of НА-Alg samples, dried at 37 оС and sintered at 700 оС. 
 
Sample 
LScherrer, nm 
LCSR, 
nm 
ε, 
10
–3
 
a, nm c, nm 
(002) (211) (112) (300) (202) (401) (213)     
37 
оС 25.5 – – – – – – 23.0 1.839 0.9354 0.6881 
700 
оС 37.4 28.7 25.9 26.3 37.4 29.7 35.2 33.8 0.497 0.9373 0.6865 
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The calculation of an a and c cell parameters showed their significantly lower values 
(Table 1) compared with the corresponding ones for the stoichiometric hydroxyapatite (а=0.9421 
nm; с=0.6881 nm). It could be assumed that carbonate ions from reactive solution were adsorbed 
by HA surface during synthesis process. The further RFA analysis showed that calcium deficient 
carbonate-containing hydroxyapatite (Са/Р=1.52) was obtained. FTIR studies confirmed this 
result. It is known from literature sources [52] that B-type carbonate apatite is characterized by 
the decrease of the lattice parameter a. In addition, there are direct evidences that calcium 
deficient HA contains HРО4
2– 
ions and is scarce on OH
–
 ions. The previous fact is confirmed by 
the FTIR spectra of the samples, where the librational mode of ОН– groups in HA at 630 cm−1 is 
not intensive and is overlapped by other vibrations. The value of microstrains (ε) is higher in the 
sample, dried at 37 
o
C due to the presence of an organic component. 
 
3.3. FTIR investigations 
The characteristic infrared bands of the experimental samples are shown in Fig. 3. For the 
comparison are given the additional data on the vibrations in pure HA and Alg (Table 2). 
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Fig. 3. FTIR spectra for investigated samples.  
Table 2. Characteristic IR bands of investigated samples. 
Sample/vibrational frequency (cm
−1
) Assignments 
HA-Alg 
(37) 
НA-Alg 
(700) 
HA-Alg/ 
MWCNT +Fe 
Alg HA 
476 472 472   ν2 O-P-O in РО4 
564 570 564 572 564 ν4 РО4 
600 602 604  602 ν4 РО4 
- - -  630(week) ОН librational 
mode 
872 876 874   ν 2 СО3
2- 
960 958 -  962 ν1  P-OinРО4 
1038 1042 1034  1044 ν3 P-O in РО4 
1090 1092 1096  1092 ν3 РО4 
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1430 - 1428 1422 - COO stretch sym. 
- - 1488  - C=C stretch 
1614 - 1634 1626  ν2 Н-О-Н;–C=O 
2340 2334 2336   ν2 СО2  
3416 - 3430 2924  ОН stretch 
3570 3576 3570 3438 3428 ОН stretch  
 
 The FTIR spectra of the samples are presented in Fig. 3. In the spectra of HA-Alg(37) 
the hydroxyl stretching band of HA appeared at 3570 cm
-1
, and the adsorbed water led to the 
broad bands centered at 1614 and 3416 cm
-1
 [53, 54]. The double peaks at 564 and 600 cm
-1
 
were caused by the O–P–O bending mode (ν4) of the phosphate group. The peak at 960 cm
-1
 
corresponded to the P–O symmetric stretching mode (ν1) of this group. The peaks at 1038 and 
1090 cm
-1
 should be attributed to the asymmetric stretching mode (ν3) of the P–O bond [55]. The 
weak bands at 872 cm
-1
 and 1430 cm
-1
 can be ascribed to carbonate groups, which substituted the 
PO4
3-
 groups in Ca-deficient HA [56]. The characteristic peaks of Alg appeared at 3438, 1626 
and 1422 cm
-1
, corresponding to hydroxyl (OH), carbonyl (C=O) and carboxyl (COOH), 
respectively [57,58]. These bands are combined with the vibration bands of HA in the HA-Alg 
(37) spectra. In the FTIR spectra of HA-Alg (700) after the sintering there are no peaks 
associated with adsorbed water molecules (1614 and 3416 cm
-1
). In the HA-Alg/MWCNT+Fe 
spectra adsorption band at 1428 cm
-1
, corresponding to the symmetric stretching vibration of the 
COO
-
 groups, is shifted compared to HA-Alg (37) and Alg (1430 and 1422 cm
-1
, respectively). 
The peak at 2928 сm-1 in HA-Alg (37), that is attributed to stretching vibrations of the hydrogen 
bonded OH
-
 groups in carbon acids [58], is disappeared in HA-Alg/MWCNT+Fe spectra. A band 
at 1488 cm
-1
 was observed for MWCNT+Fe, which can be assigned to the C=C stretching mode 
of the CNT network [17]. It can be assumed that carboxyl groups of the Alg molecules are 
ionized to COO
-
 ions and form bonding during НA-Alg/MWCNT+Fe composite formation. 
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3.4. TGA/DТА investigation 
In studying the thermal behavior of the sample when heated to 600 °C, two areas of mass loss 
were noted: in the temperature range up to 100 °C (removal of water, the presence of which is 
confirmed by the data of FTIR spectroscopy) and in the range 200-400 °C (about 10%,  removal 
of the organic component) (Fig. 4). It is in a good agreement with the literature data [59,60] 
stating that adsorbed water is gone after heating at a temperature range from 25 to 120 
oС; 
structural water – between 120 and 300 oС; the loss of carbonate and organic components begins 
at 550 
oС.  
 
 
Fig. 4. TGA/DТА of the HA-Alg sample. 
 
3.5. Swelling studies 
In order to investigate the shape stability of the experimental samples and their ability to absorb 
the drug, the swelling ratio of the experimental samples in PBS was determined. The data 
presented in Table 3. 
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Table 3. Swelling ratio of the investigated samples.  
Sample 
Swelling, % and time of imertion  
1 h 3 h  
HA-Alg 54 68 
HA-Alg/MWCNT+Fe 58 90 
 
 
Fig. 5. Appearance of samples НА-Alg (the left tubes) and HA-Alg/MWCNT+Fe (the right 
tubes): immediately after being placed in PBS (a); after 7 days shaking in PBS at 37 
o
C (b). 
 Despite the fact that the results of the experiment showed a higher degree of swelling 
of samples with carbon tube contents, they showed greater shape stability under the influence of 
mechanical vibrations compared to НА-Alg (Fig. 5). The HA-Alg/MWCNT+Fe beads retained 
shape stability even after 7 days of shaking. At the same time, NA-Alg beads after 2 days of stay 
under the specified technological conditions began to lose their shape and after 7 days they 
became the form of colloidal solution (Fig. 5,b). These results can be explained by the fact that 
when the MWCNT+Fe powder is introduced into composite material by the synthesis, the 
polyelectrolyte reactions between Alg, HA and MWCNT+Fe take place. In this case the 
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enhancing of cross-linking rate provides more stable beads form. So, the ability of НА-Alg beads 
to maintain their structural integrity is enhanced with MWCNT+Fe addition. 
 
3.6. Bioactivity studies 
Bioactivity tests were carried out by soaking the samples in PBS with pH=7.47. The glass tubes 
with 0.2 mg of each sample beads shaked in 10 ml of PBS with 60 rpm at 37 
0
C. The pH values 
measured after a certain time intervals and results presented in Fig. 6. he pure PBS was used as 
a control. 
 
 
 
 
Fig. 6. Changes of pH values in PBS due to the immersion of the samples. 
 
 Bioactivity test showed, that pH of the control PBS (without experimental samples) 
remained constant during the experiment (Fig. 6). At the same time, the pH values of PBS with 
immersed samples varied throughout the experiment, that indicates their bioactivity, which 
depends on the crystallite sizes, grain sizes, shape and defectiveness. A decrease of the pH 
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values for HA-Alg and HA-Alg/MWCNT+Fe samples during the first 5 h could be due to the 
presence of amorphous calcium phosphate phase (ACP) and its transformation into the stable HA 
phase causing the release of acidic ion of HPO4
2- 
[61]. The increase of pH values after 5 h is due 
to the partial dissolution on the sample surfaces and indicates the high reactivity of these 
materials. These facts are in agreement with the formation mechanisms of the new apatite layer 
on the bioactive surface –an exchange occurs between Ca2+ and H+ or H3O
+
 from the solution. 
Such exchanges provoke an increase of the pH that favors the formation of apatite nuclei [62]. 
The gradual increase of the pH values could also be due to the presence of carbonate impurities 
[63]. In this context it is important to note that MWCNT as well as MWCNT+Fe nanoparticles 
do not manifest any toxic effect in vitro at the concentrations used in our experiment [64,65]. 
 
3.7. HPLC study 
For HPLC studies were prepared the samples containing CH, as a reference drug. The CH is 
active against gram-positive and gram-negative organisms, facultative anaerobes, aerobes, and 
yeasts [66]. It is used in disinfectants (disinfection of the skin and hands), cosmetics (additive to 
creams, toothpaste, deodorants, and antiperspirants), and pharmaceutical products (preservative 
in eye drops, active substance in wound dressings and antiseptic mouthwashes [67]. The CH was 
introduced into composites by the method of saturation. For this, 0.2 g of each sample (HA-Alg 
and HA-Alg/MWCNT+Fe) was immersed in 4 ml of CH solution for 60 min with following 
drying at 37 
o
C. In order to evaluate the CH release kinetics, the each drug contained sample was 
placed to the tube with 15 ml of PBS. The tubes with samples were shaked (rpm 115, 
temperature 37 
o
C) for 120 h. The quantity of released CH was plotted against the incubation 
time (Fig. 7).  
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Fig. 7. CH release kinetic from the HA-Alg and HA-Alg/MWCNT+Fe beads. 
 
 
 In the Fig. 7 we observe 3 main stages of the CH release: for the first 2 h, within 24 h, 
after 24 h. The driving force of the process is the concentration gradient CH in the system 
“composite (maximum concentration) - PBS (zero concentration)”. Studies have shown that 
during the first 2 h, the release of the drug from both samples occurs with practically the same 
speed. It is evident that the first stage of drug release is due to surface molecules of CH, which 
have less binding energy to the composite surface. The second stage of the drug release is the 
result of a slow exchange of CH molecules with water molecules of the PBS due to swelling of 
the sample. The third intensive release stage after 24 h of shaking in PBS is due to the partial 
destruction of the composite shape and structure, as a result of maximum hydration, that led to 
increase of drug diffusion ability. A full release of the drug, absorbed by HA-Alg sample, took 
place for 96 h of shaking in PBS. The CH release from HA-Alg/MWCNT+Fe lasted for 120 h. 
The release rate from the HA-Alg sample is higher compared to HA-Alg/MWCNT+Fe one. The 
presence of MWCNT+Fe significantly inhibits this process and the drug release time from HA-
Alg/MWCNT+Fe is prolonged. It is obviously connected with the features of the interaction 
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mechanism of the surface MWCNT+Fe with CH. The ability of HA-Alg to maintain its 
structural integrity and shape stability is enhanced with MWCNT+Fe addition (Fig. 5).   
 
3.8. Compressive strength studies 
The results of the studies of compressive strength of different types of HA-based composites are 
presented in Table 4 and Fig. 8.  
Table 4. Strength properties of HA-based composites. 
Specimen  Density, 
g/cm
3
 
Maximal relative 
deformation, destr 
Strength c, 
MPa 
Young's 
modulus E, 
MPa  
HA-Alg 2.21 0.25 118 570 
HA-
Alg/MWCNT+Fe 
2.27 0.23 168 740 
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Fig. 8. Strength c of the HA-Alg and HA-Alg/MWCNT+Fe beads measured at uniaxial 
compression. 
As one can seen from Fig. 8, the addition of MWCNT+Fe into HA-Alg increases the 
compressive strength of specimen. The maximal relative deformations destr before destruction 
are approximately equal to ~0.23-0.25 for two types of specimens. In general, such increase of 
strength for HA-Alg-MWCNT+Fe sample is related to high aspect ratio and excellent 
mechanical properties of MWCNT. On the other hand, it is known [68], that the interfacial 
adhesion between the composite components determines the load, which will be transferred 
between them. Thus, the increase of the strength for HA-Alg/MWCNT+Fe may be also 
explained by well bonding of MWCNT+Fe nanoparticles to the HA-Alg matrix, that leads to 
efficient stress transfer at the MWCNT+Fe.  
Finally, the Young's modulus (E) estimation for three compression-unloading cycles of 
the samples has shown that they had a fairly high Young's modulus, namely E~570 MPa for HA-
Alg and E~740 MPa for HA-Alg/MWCNT+Fe, that is comparable to a steel sample of the same 
size (E~706 MPa).  
Thus, a composite material HA-Alg/MWCNT+Fe in the form of beads was created and 
studied. Each ingredient of a composite performs its main function: HA provides 
osteoconductivity and biocompatibility; Alg promotes homogenization of the composite 
material, increases biocompatibility, gives the material plasticity, makes it possible to form the 
beads; MWCNTs+Fe enhances mechanical properties, affect the dynamics of drug release. The 
ability of Alg to gelation provides the creation of a biopolymer matrix with the immobilized 
particles of the inorganic component (HA, MWCNT+Fe). The mixing Alg with MWCNT+Fe 
powder, followed by ultrasound processing during synthesis leads to the formation of a 
homogeneous colloidal solution. Alg promotes to the uniform distribution of MWCNT+Fe 
particles, since the carboxylic groups of the biopolymer form complexes with iron ions, which is 
proved by the FTIR results. The cross-linking of Alg molecules with calcium ions at the last 
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stage of synthesis leads to the formation of biopolymer apatite beads. This form of material 
provides filling of bone defects of complex geometry with a minimum gap between the bone and 
the implant. The spaces between the beads will act as a macropore and will contribute to the 
formation of new bone tissue throughout the volume of the implant. 
Conclusions 
Thus, the novel polymer-apatite composite material containing MWCNT+Fe nanoparticles was 
synthesized by the method of "wet chemistry". The interaction between organic and inorganic 
components in the composite material has been proved by FTIR spectroscopy. When the 
MWCNT+Fe powder is introduced into composite material the polyelectrolyte reaction between 
Alg, HA and MWCNT+Fe takes place. Тhe ability of НА-Alg beads to maintain its structural 
integrity is enhanced with MWCNT+Fe addition. The drug release from HA-Alg/MWCNT+Fe 
continued 24 h longer, compared to HA-Alg, that connected with the features of the interaction 
mechanism of the surface MWCNT+Fe with CH. The increase of the strength for HA-
Alg/MWCNT+Fe takes place and can be also explained by well bonding of MWCNT+Fe 
nanoparticles to the HA-Alg matrix, that leads to efficient stress transfer at the MWCNT+Fe. 
Finally, HA-Alg/MWCNT+Fe sample is characterized by a high Young's modulus comparable 
to steel. 
 Hence, this novel composite material opens the possibility of its use in bioengineering 
of bone tissue to fill bone defects of various geometries with the function of prolonged release of 
the drug. Potentially the material can be used in 3D modeling of areas of bone tissue that have to 
bear a mechanical load. 
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Highlights  
 
 “Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled by iron: 
preparation, properties and drug release ability”.  
  
In the submitted manuscript, we have revealed for the first time that novel bioactive composite material 
based on hydroxyapatite and multi-walled carbon nanotubes filled by iron can be synthesized by the 
"wet chemistry" method. Bioactivity test was carried out by soaking the samples in PBS. The material 
composition influence on the model drug release was studied using HPLC methods. The findings 
demonstrate the possibility for a application of the created composite material in bioengineering of 
bone tissue to fill bone defects of various geometries with the function of prolonged release of the drug. 
It is assumed that this composite material can be used in 3D modeling of areas of bone tissue that have 
to bear a mechanical load. 
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